For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.
Adverse Events Module path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Groups
Study -> Results Section -> Adverse Events Module -> Serious Events
Study -> Results Section -> Adverse Events Module -> Other Events
| Title | Description | Deaths # Affected | Deaths # At Risk | Serious # Affected | Serious # At Risk | Other # Affected | Other # At Risk | View |
|---|---|---|---|---|---|---|---|---|
| Fluticasone Furoate Nasal Spray | Subjects who received Fluticasone Furoate. | None | None | 0 | 173 | 5 | 173 | View |
| Fluticason Propionate Nasal Spray | Subjects who receive Fluticasone Propionate Nasal Spray. | None | None | 0 | 171 | 8 | 171 | View |
| Placebo - FF | Subjects who took no active drug but believed they were on Fluticasone Furoate Nasal Spray. | None | None | 0 | 176 | 10 | 176 | View |
| Placebo - FP | Subjects who took no active drug but believed they were on Fluticasone Propionate Nasal Spray. | None | None | 0 | 175 | 9 | 175 | View |
| Term | Type | Organ System | Vocab | View |
|---|---|---|---|---|
| Headache | SYSTEMATIC_ASSESSMENT | Nervous system disorders | MedDRA | View |